Post-approval studies (Phase 4)Study completedNCT02660346What this trial is testingIL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaBWho this might be right forBacteremia Sharp HealthCare 40
Not applicableLooking for participantsNCT05975671What this trial is testingReducing Empiric VAncomycin Use in Pediatric Suspected SepsisWho this might be right forSepsisSepsis MrsaSepsis Bacteremia+4 more Children's Hospital of Philadelphia 52,500
Not applicableNo Longer AvailableNCT04597242What this trial is testingExpanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA BacteremiaWho this might be right forMRSA Bloodstream InfectionMRSA BacteremiaMRSA Right-sided Endocarditis+1 more ContraFect
Post-approval studies (Phase 4)Looking for participantsNCT05137119What this trial is testingStaphylococcus Aureus Network Adaptive Platform TrialWho this might be right forStaphylococcus Aureus Bacteremia University of Melbourne 8,000
Not applicableLooking for participantsNCT06958835What this trial is testingLinezolid Plus Standard of CareWho this might be right forStaphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) University Hospital, Basel, Switzerland 606
Testing effectiveness (Phase 2)Ended earlyNCT01975662What this trial is testingVancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) BacteremiaWho this might be right forBacteremia Due to Staphylococcus Aureus Singapore General Hospital 14
Not applicableStudy completedNCT01184339What this trial is testingProspective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture PositivesWho this might be right forBacteremia MicroPhage, Inc. 1,165
Testing effectiveness (Phase 2)WithdrawnNCT05329168What this trial is testingERAdicate S. Aureus in Patients With Bacteremia and EndocarditisWho this might be right forBacteremia Due to Staphylococcus AureusLeft Sided Infective Endocarditis (Disorder)Right Sided Infective Endocarditis (Disorder)+1 more Lysovant
Post-approval studies (Phase 4)Looking for participantsNCT06637332What this trial is testingDaptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus BacteremiaWho this might be right forStaphylococcus Aureus SepticemiaStaphylococcus Aureus BacteremiaS. Aureus Bacteremia+2 more Todd C. Lee MD MPH FIDSA 300
Post-approval studies (Phase 4)Ended earlyNCT00638157What this trial is testingPhase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)Who this might be right forInfective Endocarditis Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Not applicableEnded earlyNCT01640886What this trial is testingStudy of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTAWho this might be right forBacteremia MicroPhage, Inc. 764
Large-scale testing (Phase 3)Study completedNCT01898338What this trial is testingEfficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA BacteremiaWho this might be right forStaph Aureus Methicillin Resistant Bacteremia Miquel Pujol 167
Testing effectiveness (Phase 2)Study completedNCT03643952What this trial is testingSafety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)Who this might be right forBacteremiaSoft Tissue InfectionsSkin Diseases, Infectious Merck Sharp & Dohme LLC 18
Large-scale testing (Phase 3)Ended earlyNCT01515020What this trial is testingDaptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA BacteremiaWho this might be right forNosocomial InfectionHealthcare-associated Infection Assistance Publique - Hôpitaux de Paris 10
Post-approval studies (Phase 4)Study completedNCT01701219What this trial is testingSafety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus Aureus BacteremiaMethicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia Forest Laboratories 56
Post-approval studies (Phase 4)Ended earlyNCT01287832What this trial is testingVancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs)Who this might be right forBacteremia St. John Health System, Michigan 11
Testing effectiveness (Phase 2)Ended earlyNCT03089697What this trial is testingPhase IIa Clinical Study of N-Rephasin® SAL200Who this might be right forStaphylococcus Aureus BacteremiaAnti-Bacterial Agents Intron Biotechnology, Inc. 25
Not applicableUnknownNCT01352936What this trial is testingComparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin TherapyWho this might be right forStaphylococcus AureusBacteremia Taipei Medical University WanFang Hospital 190
Large-scale testing (Phase 3)Study completedNCT00427076What this trial is testingCotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus InfectionsWho this might be right forStaphylococcal InfectionsMeningitisSepsis+1 more Rabin Medical Center 252
Large-scale testing (Phase 3)Study completedNCT01967225What this trial is testingSafety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) InfectionsWho this might be right forSkin Diseases, Infectious Bayer 125